1,953 reports of this reaction
7.5% of all DOCOSANOL reports
#3 most reported adverse reaction
CONDITION AGGRAVATED is the #3 most commonly reported adverse reaction for DOCOSANOL, manufactured by Haleon US Holdings LLC. There are 1,953 FDA adverse event reports linking DOCOSANOL to CONDITION AGGRAVATED. This represents approximately 7.5% of all 26,055 adverse event reports for this drug.
Patients taking DOCOSANOL who experience condition aggravated should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CONDITION AGGRAVATED is moderately reported among DOCOSANOL users, representing a notable but not dominant share of adverse events.
In addition to condition aggravated, the following adverse reactions have been reported for DOCOSANOL:
The following drugs have also been linked to condition aggravated in FDA adverse event reports:
CONDITION AGGRAVATED has been reported as an adverse event in 1,953 FDA reports for DOCOSANOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
CONDITION AGGRAVATED accounts for approximately 7.5% of all adverse event reports for DOCOSANOL, making it one of the most commonly reported side effect.
If you experience condition aggravated while taking DOCOSANOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.